POLYSACCHARIDE-K INDUCES MN SUPEROXIDE-DISMUTASE (MN-SOD) IN TUMOR-TISSUES AND INHIBITS MALIGNANT PROGRESSION OF QR-32 TUMOR-CELLS - POSSIBLE ROLES OF INTERFERON-ALPHA, TUMOR-NECROSIS-FACTOR-ALPHA AND TRANSFORMING-GROWTH-FACTOR-BETA IN MN-SOD INDUCTION BY POLYSACCHARIDE-K
H. Habelhah et al., POLYSACCHARIDE-K INDUCES MN SUPEROXIDE-DISMUTASE (MN-SOD) IN TUMOR-TISSUES AND INHIBITS MALIGNANT PROGRESSION OF QR-32 TUMOR-CELLS - POSSIBLE ROLES OF INTERFERON-ALPHA, TUMOR-NECROSIS-FACTOR-ALPHA AND TRANSFORMING-GROWTH-FACTOR-BETA IN MN-SOD INDUCTION BY POLYSACCHARIDE-K, Cancer immunology and immunotherapy, 46(6), 1998, pp. 338-344
Previously we reported the malignant progression of QR-32, a regressor
-type tumor clone, following co-implantation with foreign bodies (gela
tin sponge or plastic plate) in normal syngeneic C57BL/6 mice. We also
reported that the progression of QR-32 cells by a gelatin sponge was
significantly inhibited in the mice administered polysaccharide K (PSK
) and that PSK induced an increase of radical scavengers, especially m
anganese superoxide dismutase (Mn-SOD), locally at the site of tumor t
issues. In this study, to reveal the possible mechanism by which PSK i
nduced Mn-SOD in the tumor tissues, we examined the mRNA expression an
d protein levels of inflammatory cytokines in the tissues. We found th
at mRNAs of tumor necrosis factor alpha (TNF alpha) and interleukin-1
alpha (IL-1 alpha) were considerably expressed in both PSK-treated and
phosphate-buffered-saline-treated tumors, and that the mRNA expressio
n and protein level of interferon gamma (IFN gamma) increased in the t
umor tissues treated with PSK. In vitro treatment of QR-32 cells with
IFN gamma did not significantly increase the production of Mn-SOD; how
ever, the combination of IFN gamma with TNF alpha increased the Mn-SOD
production more effectively than did any of the cytokines used singly
. Furthermore, we observed the down-regulation of the mRNA expression
and protein level of transforming growth factor beta (TGF beta) in the
tumor tissues treated with PSK, and that in vitro treatment of QR-32
cells with TGF beta decreased the production of Mn-SOD. These results
suggest that PSK suppresses the progression of QR-32 cells by increasi
ng Mn-SOD via the modulation of inflammatory cytokines; that is, by de
creasing TGF-beta and increasing IFN-gamma.